{"id":3855,"date":"2000-06-01T00:00:00","date_gmt":"2000-06-01T04:00:00","guid":{"rendered":"https:\/\/icesontario.wpengine.com\/journal-articles\/subgroups-treatment-effects-and-baseline-risks-some-lessons-from-major-cardiovascular-trials\/"},"modified":"2023-06-14T19:47:22","modified_gmt":"2023-06-14T23:47:22","slug":"subgroups-treatment-effects-and-baseline-risks-some-lessons-from-major-cardiovascular-trials","status":"publish","type":"journal_article","link":"https:\/\/www.ices.on.ca\/fr\/publications\/journal-articles\/subgroups-treatment-effects-and-baseline-risks-some-lessons-from-major-cardiovascular-trials\/","title":{"rendered":"Subgroups, treatment effects, and baseline risks: some lessons from major cardiovascular trials"},"content":{"rendered":"<p><strong>Background<\/strong> &#x2014; The objective of this study was to determine how subgroup analyses are performed in large randomized trials of cardiovascular pharmacotherapy. <\/p>\n<p><span class=\"bold\">Methods and Results<\/span> &#x2014; We reviewed 67 randomized, double-blind, controlled trials involving pharmacotherapy in at least 1000 patients with unstable angina, myocardial infarction, left ventricular dysfunction, or heart failure with clinical outcomes as primary end points, published between 1980 and 1997. Nine had no subgroup analyses but 43 reported on 5 or more subgroups and 31 reported subgroups without formal statistical tests for treatment-subgroup interactions. In most trials, a rationale for subgroup selection was missing. All but 6 focused on single-factor subgroups. <\/p>\n<p><strong>Conclusions<\/strong> &#x2014; Trial subgroups should ideally be defined a priori on 2 bases: single-factor subgroups with a strong rationale for biological response modification and multifactorial prognostic subgroups defined from baseline risks. However, single-factor subgroup analyses are often reported without a supporting rationale or formal statistical tests for interactions. We suggest that clinicians should interpret published subgroup-specific variations in treatment effects skeptically unless there is a prespecified rationale and a significant treatment-subgroup interaction.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Background &#x2014; The objective of this study was to determine how subgroup analyses are performed in large randomized trials of cardiovascular pharmacotherapy. Methods and Results &#x2014; We reviewed 67 randomized, double-blind, controlled trials involving pharmacotherapy in at least 1000 patients with unstable angina, myocardial infarction, left ventricular dysfunction, or heart failure with clinical outcomes as [&hellip;]<\/p>\n","protected":false},"template":"","migration-helper-automated":[],"migration-manual":[],"topic":[40,31],"migration-helper-qa-sample-set":[],"class_list":["post-3855","journal_article","type-journal_article","status-publish","hentry","topic-cardiovascular-disease","topic-pharmacy"],"acf":{"citation":"Parker AB, Naylor CD. <em>Am Heart J<\/em>. 2000; 139(6):952-61.","source_url":"","ices_scientist":[1304],"site":[6733],"research_program":[],"news_release":[],"journal_article":[],"atlas":[],"research_report":[],"infographic":[],"video":[],"downloads":null,"links":null,"sitecore_item_id":"CF26C784-BE71-452C-8A52-86590FB5123D","sitecore_item_name":"Subgroups-treatment-effects-and-baseline-risks-some-lessons-from-major-cardiovascular-trials","sitecore_field_values":"{\n  \"Title\": \"Subgroups, treatment effects, and baseline risks: some lessons from major cardiovascular trials\",\n  \"Short title\": \"Subgroups, treatment effects, and\",\n  \"Citation\": \"<p>Parker AB, Naylor CD. <em>Am Heart J<\/em>. 2000; 139(6):952-61.<\/p>\",\n  \"Abstract\": \"<p><strong>Background<\/strong> &mdash; The objective of this study was to determine how subgroup analyses are performed in large randomized trials of cardiovascular pharmacotherapy. <\/p>rn<p><span class=\"bold\">Methods and Results<\/span> &mdash; We reviewed 67 randomized, double-blind, controlled trials involving pharmacotherapy in at least 1000 patients with unstable angina, myocardial infarction, left ventricular dysfunction, or heart failure with clinical outcomes as primary end points, published between 1980 and 1997. Nine had no subgroup analyses but 43 reported on 5 or more subgroups and 31 reported subgroups without formal statistical tests for treatment-subgroup interactions. In most trials, a rationale for subgroup selection was missing. All but 6 focused on single-factor subgroups. <\/p>rn<p><strong>Conclusions<\/strong> &mdash; Trial subgroups should ideally be defined a priori on 2 bases: single-factor subgroups with a strong rationale for biological response modification and multifactorial prognostic subgroups defined from baseline risks. However, single-factor subgroup analyses are often reported without a supporting rationale or formal statistical tests for interactions. We suggest that clinicians should interpret published subgroup-specific variations in treatment effects skeptically unless there is a prespecified rationale and a significant treatment-subgroup interaction.<\/p>\",\n  \"Keywords\": \"{92E2791D-5DAB-4244-8A85-434D524D9A12}|{0D3BD683-F179-40A8-924F-D7895622D238}|{98F255F7-00F2-411A-97F2-5AB8FBF78D8C}\",\n  \"ICES Locations\": \"{4FCAABBA-14A5-42E6-8F33-BC6C2F1D9908}\",\n  \"ICES Scientists\": \"{545C70EB-0A3F-4646-A0F5-509EB7E15CF6}\",\n  \"Posted Date\": \"20000601T000000\"\n}","previous_url":"https:\/\/www.ices.on.ca\/Publications\/Journal-Articles\/2000\/January\/Subgroups-treatment-effects-and-baseline-risks-some-lessons-from-major-cardiovascular-trials"},"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>ICES | Subgroups, treatment effects, and baseline risks: some lessons from major cardiovascular trials<\/title>\n<meta name=\"description\" content=\"Background &#x2014; The objective of this study was to determine how subgroup analyses are performed in large randomized trials of cardiovascular\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.ices.on.ca\/fr\/publications\/journal-articles\/subgroups-treatment-effects-and-baseline-risks-some-lessons-from-major-cardiovascular-trials\/\" \/>\n<meta property=\"og:locale\" content=\"fr_FR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"ICES | Subgroups, treatment effects, and baseline risks: some lessons from major cardiovascular trials\" \/>\n<meta property=\"og:description\" content=\"Background &#x2014; The objective of this study was to determine how subgroup analyses are performed in large randomized trials of cardiovascular\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.ices.on.ca\/fr\/publications\/journal-articles\/subgroups-treatment-effects-and-baseline-risks-some-lessons-from-major-cardiovascular-trials\/\" \/>\n<meta property=\"og:site_name\" content=\"ICES\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/ICESOntario\/\" \/>\n<meta property=\"article:modified_time\" content=\"2023-06-14T23:47:22+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.ices.on.ca\/wp-content\/uploads\/2024\/11\/ic-es-data-discovery-better-health-logo.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1200\" \/>\n\t<meta property=\"og:image:height\" content=\"675\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.ices.on.ca\\\/fr\\\/publications\\\/journal-articles\\\/subgroups-treatment-effects-and-baseline-risks-some-lessons-from-major-cardiovascular-trials\\\/\",\"url\":\"https:\\\/\\\/www.ices.on.ca\\\/fr\\\/publications\\\/journal-articles\\\/subgroups-treatment-effects-and-baseline-risks-some-lessons-from-major-cardiovascular-trials\\\/\",\"name\":\"ICES | Subgroups, treatment effects, and baseline risks: some lessons from major cardiovascular trials\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.ices.on.ca\\\/fr\\\/#website\"},\"datePublished\":\"2000-06-01T04:00:00+00:00\",\"dateModified\":\"2023-06-14T23:47:22+00:00\",\"description\":\"Background &#x2014; The objective of this study was to determine how subgroup analyses are performed in large randomized trials of cardiovascular\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.ices.on.ca\\\/fr\\\/publications\\\/journal-articles\\\/subgroups-treatment-effects-and-baseline-risks-some-lessons-from-major-cardiovascular-trials\\\/#breadcrumb\"},\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.ices.on.ca\\\/fr\\\/publications\\\/journal-articles\\\/subgroups-treatment-effects-and-baseline-risks-some-lessons-from-major-cardiovascular-trials\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.ices.on.ca\\\/fr\\\/publications\\\/journal-articles\\\/subgroups-treatment-effects-and-baseline-risks-some-lessons-from-major-cardiovascular-trials\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.ices.on.ca\\\/fr\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Journal Articles\",\"item\":\"https:\\\/\\\/www.ices.on.ca\\\/fr\\\/publications\\\/journal-articles\\\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"Subgroups, treatment effects, and baseline risks: some lessons from major cardiovascular trials\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.ices.on.ca\\\/fr\\\/#website\",\"url\":\"https:\\\/\\\/www.ices.on.ca\\\/fr\\\/\",\"name\":\"ICES\",\"description\":\"POPULATION-BASED HEALTH RESEARCH THAT MAKES A DIFFERENCE\",\"publisher\":{\"@id\":\"https:\\\/\\\/www.ices.on.ca\\\/fr\\\/#organization\"},\"alternateName\":\"Institute for Clinical Evaluative Sciences\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.ices.on.ca\\\/fr\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"fr-FR\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/www.ices.on.ca\\\/fr\\\/#organization\",\"name\":\"ICES\",\"alternateName\":\"Institute for Clinical Evaluative Sciences\",\"url\":\"https:\\\/\\\/www.ices.on.ca\\\/fr\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\\\/\\\/www.ices.on.ca\\\/fr\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/www.ices.on.ca\\\/wp-content\\\/uploads\\\/2023\\\/04\\\/ices-logo.png\",\"contentUrl\":\"https:\\\/\\\/www.ices.on.ca\\\/wp-content\\\/uploads\\\/2023\\\/04\\\/ices-logo.png\",\"width\":\"676\",\"height\":\"618\",\"caption\":\"ICES\"},\"image\":{\"@id\":\"https:\\\/\\\/www.ices.on.ca\\\/fr\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/ICESOntario\\\/\",\"https:\\\/\\\/www.linkedin.com\\\/company\\\/ices-research-institute\\\/\"]}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"ICES | Subgroups, treatment effects, and baseline risks: some lessons from major cardiovascular trials","description":"Background &#x2014; The objective of this study was to determine how subgroup analyses are performed in large randomized trials of cardiovascular","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.ices.on.ca\/fr\/publications\/journal-articles\/subgroups-treatment-effects-and-baseline-risks-some-lessons-from-major-cardiovascular-trials\/","og_locale":"fr_FR","og_type":"article","og_title":"ICES | Subgroups, treatment effects, and baseline risks: some lessons from major cardiovascular trials","og_description":"Background &#x2014; The objective of this study was to determine how subgroup analyses are performed in large randomized trials of cardiovascular","og_url":"https:\/\/www.ices.on.ca\/fr\/publications\/journal-articles\/subgroups-treatment-effects-and-baseline-risks-some-lessons-from-major-cardiovascular-trials\/","og_site_name":"ICES","article_publisher":"https:\/\/www.facebook.com\/ICESOntario\/","article_modified_time":"2023-06-14T23:47:22+00:00","og_image":[{"width":1200,"height":675,"url":"https:\/\/www.ices.on.ca\/wp-content\/uploads\/2024\/11\/ic-es-data-discovery-better-health-logo.jpg","type":"image\/jpeg"}],"twitter_card":"summary_large_image","schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.ices.on.ca\/fr\/publications\/journal-articles\/subgroups-treatment-effects-and-baseline-risks-some-lessons-from-major-cardiovascular-trials\/","url":"https:\/\/www.ices.on.ca\/fr\/publications\/journal-articles\/subgroups-treatment-effects-and-baseline-risks-some-lessons-from-major-cardiovascular-trials\/","name":"ICES | Subgroups, treatment effects, and baseline risks: some lessons from major cardiovascular trials","isPartOf":{"@id":"https:\/\/www.ices.on.ca\/fr\/#website"},"datePublished":"2000-06-01T04:00:00+00:00","dateModified":"2023-06-14T23:47:22+00:00","description":"Background &#x2014; The objective of this study was to determine how subgroup analyses are performed in large randomized trials of cardiovascular","breadcrumb":{"@id":"https:\/\/www.ices.on.ca\/fr\/publications\/journal-articles\/subgroups-treatment-effects-and-baseline-risks-some-lessons-from-major-cardiovascular-trials\/#breadcrumb"},"inLanguage":"fr-FR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.ices.on.ca\/fr\/publications\/journal-articles\/subgroups-treatment-effects-and-baseline-risks-some-lessons-from-major-cardiovascular-trials\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/www.ices.on.ca\/fr\/publications\/journal-articles\/subgroups-treatment-effects-and-baseline-risks-some-lessons-from-major-cardiovascular-trials\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.ices.on.ca\/fr\/"},{"@type":"ListItem","position":2,"name":"Journal Articles","item":"https:\/\/www.ices.on.ca\/fr\/publications\/journal-articles\/"},{"@type":"ListItem","position":3,"name":"Subgroups, treatment effects, and baseline risks: some lessons from major cardiovascular trials"}]},{"@type":"WebSite","@id":"https:\/\/www.ices.on.ca\/fr\/#website","url":"https:\/\/www.ices.on.ca\/fr\/","name":"ICES","description":"POPULATION-BASED HEALTH RESEARCH THAT MAKES A DIFFERENCE","publisher":{"@id":"https:\/\/www.ices.on.ca\/fr\/#organization"},"alternateName":"Institute for Clinical Evaluative Sciences","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.ices.on.ca\/fr\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"fr-FR"},{"@type":"Organization","@id":"https:\/\/www.ices.on.ca\/fr\/#organization","name":"ICES","alternateName":"Institute for Clinical Evaluative Sciences","url":"https:\/\/www.ices.on.ca\/fr\/","logo":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/www.ices.on.ca\/fr\/#\/schema\/logo\/image\/","url":"https:\/\/www.ices.on.ca\/wp-content\/uploads\/2023\/04\/ices-logo.png","contentUrl":"https:\/\/www.ices.on.ca\/wp-content\/uploads\/2023\/04\/ices-logo.png","width":"676","height":"618","caption":"ICES"},"image":{"@id":"https:\/\/www.ices.on.ca\/fr\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/ICESOntario\/","https:\/\/www.linkedin.com\/company\/ices-research-institute\/"]}]}},"_links":{"self":[{"href":"https:\/\/www.ices.on.ca\/fr\/wp-json\/wp\/v2\/journal_article\/3855","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.ices.on.ca\/fr\/wp-json\/wp\/v2\/journal_article"}],"about":[{"href":"https:\/\/www.ices.on.ca\/fr\/wp-json\/wp\/v2\/types\/journal_article"}],"acf:post":[{"embeddable":true,"href":"https:\/\/www.ices.on.ca\/fr\/wp-json\/wp\/v2\/site\/6733"},{"embeddable":true,"href":"https:\/\/www.ices.on.ca\/fr\/wp-json\/wp\/v2\/ices_scientist\/1304"}],"wp:attachment":[{"href":"https:\/\/www.ices.on.ca\/fr\/wp-json\/wp\/v2\/media?parent=3855"}],"wp:term":[{"taxonomy":"migration-helper-automated","embeddable":true,"href":"https:\/\/www.ices.on.ca\/fr\/wp-json\/wp\/v2\/migration-helper-automated?post=3855"},{"taxonomy":"migration-manual","embeddable":true,"href":"https:\/\/www.ices.on.ca\/fr\/wp-json\/wp\/v2\/migration-manual?post=3855"},{"taxonomy":"topic","embeddable":true,"href":"https:\/\/www.ices.on.ca\/fr\/wp-json\/wp\/v2\/topic?post=3855"},{"taxonomy":"migration-helper-qa-sample-set","embeddable":true,"href":"https:\/\/www.ices.on.ca\/fr\/wp-json\/wp\/v2\/migration-helper-qa-sample-set?post=3855"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}